GB1422745A - Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same - Google Patents
Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using sameInfo
- Publication number
- GB1422745A GB1422745A GB3021973A GB3021973A GB1422745A GB 1422745 A GB1422745 A GB 1422745A GB 3021973 A GB3021973 A GB 3021973A GB 3021973 A GB3021973 A GB 3021973A GB 1422745 A GB1422745 A GB 1422745A
- Authority
- GB
- United Kingdom
- Prior art keywords
- animal
- benzotriazine
- hydroxy
- behaviour
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- DMSSTTLDFWKBSX-UHFFFAOYSA-N 1h-1,2,3-benzotriazin-4-one Chemical compound C1=CC=C2C(=O)N=NNC2=C1 DMSSTTLDFWKBSX-UHFFFAOYSA-N 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1422745 Inhibiting aggresive behaviour UNIROYAL INC 26 June 1973 [21 Aug 1972] 30219/73 Heading A5B A method of preventing or inhibiting aggresive behaviour in an animal comprises administering to the animal an amount of 4-hydroxy-1, 2,3-benzotriazine effective to prevent or inhibit said behaviour in the animal without simultaneously causing depression in said subject. The compound may be .administered in an orally administerable dosage form, e.g. a pill, tablet, capsule, solution or suspension, or may be parenterally administered e.g. as a solution or suspension or rectally administered e.g. as a suppository. The effective amount is preferably 2-100 mg/kg of body weight of animal per day.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28231172A | 1972-08-21 | 1972-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1422745A true GB1422745A (en) | 1976-01-28 |
Family
ID=23080926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3021973A Expired GB1422745A (en) | 1972-08-21 | 1973-06-26 | Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US3794726A (en) |
| DE (1) | DE2336586A1 (en) |
| FR (1) | FR2196806A1 (en) |
| GB (1) | GB1422745A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5234925A (en) * | 1991-08-14 | 1993-08-10 | Dana-Farber Cancer Institute, Inc. | 2-aza-2-desamino analogues of 5,8-dideazafolic acid |
| JO3719B1 (en) | 2014-11-20 | 2021-01-31 | Takeda Pharmaceuticals Co | 4-oxo-3,4-dihydro-1,2,3-benzotriazines as modulators of gpr139 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2935445A (en) * | 1957-11-21 | 1960-05-03 | American Cyanamid Co | Nu-trichloromethylthio-1, 2, 3-benzotriazine-4-one as a novel nematocide |
| US3471489A (en) * | 1968-07-29 | 1969-10-07 | Dow Chemical Co | 1,2,3-benzotriazin-4(3h)-ones |
| US3652560A (en) * | 1970-06-18 | 1972-03-28 | Dow Chemical Co | 3-((alkylthio)methyl)-1 2 3-benzotriazin-4(3h)-ones |
-
1972
- 1972-08-21 US US00282311A patent/US3794726A/en not_active Expired - Lifetime
-
1973
- 1973-06-26 GB GB3021973A patent/GB1422745A/en not_active Expired
- 1973-07-18 DE DE19732336586 patent/DE2336586A1/en active Pending
- 1973-08-20 FR FR7330183A patent/FR2196806A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| FR2196806A1 (en) | 1974-03-22 |
| DE2336586A1 (en) | 1974-02-28 |
| US3794726A (en) | 1974-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1517480A (en) | Opiate analgesic formulation with a low potential for abuse | |
| GB1459675A (en) | Method for the prevention of conception | |
| Munoz | Effect of H. pertussis on sensitivity of mice to serotonin | |
| GB1388358A (en) | Taste-improving formulations of oral penicillins | |
| Tillander et al. | EXCRETION RATE OF METHYL MERCURY IN THE SEAL(PUSA HISPIDA) | |
| GB1422193A (en) | Pharmaceutical compositions | |
| GB1422745A (en) | Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same | |
| GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
| GB1210968A (en) | Improvements in or relating to the treatment of gastric ailments | |
| GB1464467A (en) | Pharmaceutical composition for the treatment of coronary | |
| IE35419L (en) | Pharmaceutical composition containing cyclobenzaprine | |
| JPS646214A (en) | Remedy for ulcerative colonopathy | |
| US3806594A (en) | Method of reducing involuntary movements associated with cerebral palsy using clorazepate dipotassium | |
| GB1292496A (en) | Dosage units of contraceptive preparations for human use | |
| GB1375806A (en) | ||
| GB1352392A (en) | Phenylisopropylamine derivatives | |
| GB1225677A (en) | ||
| US3789124A (en) | Treatment of colitis ulcerosa | |
| GB1242001A (en) | Pharmaceutical preparations | |
| IE36780L (en) | Pharmaceutical preparations | |
| GB1127748A (en) | Pharmaceutical compositions for use in the treatment of disturbances due to luteinic deficiency | |
| GB1294538A (en) | Pharmaceutical compositions | |
| GB1327467A (en) | Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase | |
| GB1420976A (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
| SU906521A1 (en) | Contraception method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |